One-month follow up of a randomized clinical trial-phase II study in 6 to < 24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine
Typhoid fever, which is caused by enteric bacterium, Salmonella enterica serovar Typhi, is an acute generalized infection. WHO estimates the annual global incidence of typhoid fever at 11-21 million cases and approximately 128000 to 161000 deaths (World Health Organization, 2018). Children are the most affected age group with a peak incidence known to occur in individuals aged 5 to
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Bernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, Rini Sekartini, Hindra Irawan Satari, Sri Rezeki Hadinegoro, Angga Wirahmadi, Mita Puspita, Rini Mulia Sari, Jae Seung Yang, Arijit Sil, Sushant Sahastrabuddhe, Novilia Sjafri Bachtiar Source Type: research
More News: Children | Clinical Trials | Indonesia Health | Infectious Diseases | International Medicine & Public Health | Salmonella | Study | Typhoid | Typhoid Vaccine | Vaccines | WHO